Chambers C, Watakul S, Schofield P, Howell A, Zhu J, Tran A
Sci Adv. 2025; 11(11):eadq4416.
PMID: 40073121
PMC: 11900870.
DOI: 10.1126/sciadv.adq4416.
Li X, Zhao H, Jiang E, Liu P, Chen Y, Wang Y
Oncogene. 2025; .
PMID: 40044983
DOI: 10.1038/s41388-025-03317-z.
Berg S, Berg J
Front Immunol. 2025; 15:1493978.
PMID: 39981299
PMC: 11840190.
DOI: 10.3389/fimmu.2024.1493978.
Zhao B, Xuan R, Yang G, Hu T, Chen Y, Cai L
Discov Oncol. 2025; 16(1):212.
PMID: 39976877
PMC: 11842676.
DOI: 10.1007/s12672-025-01889-6.
Liao W, Wang J, Li Y
J Pharm Anal. 2025; 15(2):101075.
PMID: 39957902
PMC: 11830317.
DOI: 10.1016/j.jpha.2024.101075.
An update on cancer stem cell survival pathways involved in chemoresistance in triple-negative breast cancer.
Jan A, Sofi S, Jan N, Mir M
Future Oncol. 2025; 21(6):715-735.
PMID: 39936282
PMC: 11881842.
DOI: 10.1080/14796694.2025.2461443.
Myeloma cell-derived CXCL7 facilitates proliferation of tumor cells and occurrence of osteolytic lesions through JAK/STAT3 pathway.
Wang Y, Lan T, Zhang Q, Zhou C, Liu P
Cell Death Dis. 2025; 16(1):74.
PMID: 39915476
PMC: 11802855.
DOI: 10.1038/s41419-025-07413-6.
Timp2 loss-of-function mutation and TIMP2 treatment in a murine model of NSCLC: Modulation of immunosuppression and oncogenic signaling.
Peeney D, Kumar S, Singh T, Liu Y, Jensen S, Chowdhury A
Transl Oncol. 2025; 53:102309.
PMID: 39904284
PMC: 11846589.
DOI: 10.1016/j.tranon.2025.102309.
Micro Immune Response On-chip (MIRO) models the tumour-stroma interface for immunotherapy testing.
Perucca A, Llonin A, Benach O, Hallopeau C, Rivas E, Linares J
Nat Commun. 2025; 16(1):1279.
PMID: 39900918
PMC: 11790944.
DOI: 10.1038/s41467-025-56275-1.
Stromal architecture and fibroblast subpopulations with opposing effects on outcomes in hepatocellular carcinoma.
Cheng Y, Chen X, Feng L, Yang Z, Xiao L, Xiang B
Cell Discov. 2025; 11(1):1.
PMID: 39870619
PMC: 11772884.
DOI: 10.1038/s41421-024-00747-z.
Immune infiltration landscape and potential drug-targeted implications for hepatocellular carcinoma with 'progression/hyper-progression' recurrence.
Xu J, Su Y, Chen Y, Huang Y, Chen Z, Peng Y
Ann Med. 2025; 57(1):2456113.
PMID: 39865865
PMC: 11774162.
DOI: 10.1080/07853890.2025.2456113.
(-)-Epigallocatechin-3-Gallate and Quercetin Inhibit Quiescin Sulfhydryl Oxidase 1 Secretion from Hepatocellular Carcinoma Cells.
Yang L, Fang Y, He Y, Zhang J
Antioxidants (Basel). 2025; 14(1).
PMID: 39857439
PMC: 11763033.
DOI: 10.3390/antiox14010106.
The Dynamic Changes of COL11A1 Expression During the Carcinogenesis and Development of Breast Cancer and as a Candidate Diagnostic and Prognostic Marker.
Wang Y, Wang J
Breast J. 2025; 2025():7861864.
PMID: 39845732
PMC: 11752105.
DOI: 10.1155/tbj/7861864.
Intratumoral Collagen Deposition Supports Angiogenesis Suggesting Anti-angiogenic Therapy in Armored and Cold Tumors.
Mei J, Yang K, Zhang X, Luo Z, Tian M, Fan H
Adv Sci (Weinh). 2025; 12(10):e2409147.
PMID: 39823457
PMC: 11904994.
DOI: 10.1002/advs.202409147.
Comprehensive investigation of matrix metalloproteinases in skin cutaneous melanoma: diagnostic, prognostic, and therapeutic insights.
Wu L, Liu C, Hu W
Sci Rep. 2025; 15(1):2152.
PMID: 39820824
PMC: 11739484.
DOI: 10.1038/s41598-025-85887-2.
Bibliometric analysis of laryngeal cancer treatment literature (2003-2023).
Zhao Y, Xue J
Heliyon. 2025; 11(1):e40832.
PMID: 39811326
PMC: 11730226.
DOI: 10.1016/j.heliyon.2024.e40832.
A Thermo-responsive collapse system for controlling heterogeneous cell localization, ratio and interaction for three-dimensional solid tumor modeling.
Li Y, Orange J
bioRxiv. 2025; .
PMID: 39764015
PMC: 11703237.
DOI: 10.1101/2024.12.26.630018.
MatriCom: a scRNA-Seq data mining tool to infer ECM-ECM and cell-ECM communication systems.
Lamba R, Paguntalan A, Petrov P, Naba A, Izzi V
bioRxiv. 2025; .
PMID: 39763937
PMC: 11702561.
DOI: 10.1101/2024.12.10.627834.
Mini-open periacetabular cementoplasty for periacetabular bone metastasis: a report of two cases.
Kirisawa M, Torigoe T, Yazawa Y, Watanabe T, Kadono Y
Int Cancer Conf J. 2025; 14(1):39-45.
PMID: 39758790
PMC: 11695525.
DOI: 10.1007/s13691-024-00731-0.
Breast pericytes: a newly identified driver of tumor cell proliferation.
Del Toro K, Licon-Munoz Y, Crabtree W, Oper T, Robbins C, Hines W
Front Oncol. 2025; 14():1455484.
PMID: 39741968
PMC: 11685225.
DOI: 10.3389/fonc.2024.1455484.